Fanconi Anemia Panel by next-generation sequencing (NGS)
- GTR Test IDHelpEach Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. When a laboratory updates a registered test, a new version number is assigned.: GTR000501117.5
- Last updated: 2014-11-26
- Test version history
- 501117.9, last updated: 2023-07-31
- 501117.8, last updated: 2020-09-09
- 501117.7, last updated: 2019-09-12
- 501117.6, last updated: 2018-10-04
- 501117.5, last updated: 2014-11-26
- 501117.4, last updated: 2014-10-21
- 501117.3, last updated: 2014-06-06
- 501117.2, last updated: 2013-11-27
- 501117.1, last updated: 2013-11-27
Clinical testHelpIn the U.S., clinical tests must be performed under CLIA certification. When a lab uses the same methods for a test in both clinical and research settings, the test appears as two separate GTR records. for Fanconi's anemia
Offered by Molecular Genetics Laboratory
Overview
Test name
HelpThe name the laboratory assigns the test. Used as the default title of the page specific to the test.Fanconi Anemia Panel by next-generation sequencing (NGS)
This is a clinical test intended for HelpPurposes or indications for the test. Lab-provided.: Diagnosis, Pre-symptomatic
Click Indication tab for more information.
Complete the appropriate test requisition and have it signed by the referring physician.
Order URL HelpLink to the laboratory webpage with information about how to order this test. Please note that clicking on this link will open a new tab in your internet browser.: http://www.cincinnatichildrens.org/service/d/diagnostic-labs/molecular-genetics/requisition/
Methodology
HelpThe assay's major method category (biochemical, cytogenetic or molecular genetics); method category (i.e. enzyme assay, chromosome breakage studies, targeted mutation analysis); methodology (i.e. the name of the method used) and instruments used when performing this test.- Molecular Genetics
- CSequence analysis of the entire coding region
- Next-Generation (NGS)/Massively parallel sequencing (MPS)
- TTargeted variant analysis
- Bi-directional Sanger Sequence Analysis
Not provided
Clinical validity
HelpHow consistently and accurately the test detects or predicts the intermediate or final outcomes of interest. Lab-provided.Not provided
Testing strategy
HelpThe lab's suggested sequence of ordering tests based on clinical scenarios. It may include information on: reflex testing including each test component, and scenarios which prompt additional components of testing; whether lab communicates interim results or automatically proceeds to further analyses; and if any components are performed in another laboratory.Chromosome breakage and complementation testing can be ordered sequentially along with molecular genetic testing. Single-gene testing is also available for the genes on this panel, with the exception of FANCD1. 000 Complete the appropriate test requisition and have it signed by the referring physician.
- NCI PDQ, Skin CancerGenetics of Skin Cancer (PDQ®): Health Professional Version
- NCI PDQ, Breast and Gynecologic CancersGenetics of Breast and Gynecologic Cancers (PDQ®): Health Professional Version
- NCI PDQ, Cancer Genetics CounselingCancer Genetics Risk Assessment and Counseling (PDQ®): Health Professional Version
- FARF, 2020Fanconi Anemia Clinical Care Guidelines, Fifth Edition.
- FARF, 2008Fanconi Anemia Research Fund, Guidelines for Diagnosis and Management, 2008 (See 2020 Update)
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.